FineMark National Bank & Trust’s Enzo Biochem, Inc. ENZ Stock Holding History

FineMark National Bank & Trust’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-527	Closed	-$2K	–	1499
2015 Q3	$2K	Buy	+527	New	+$1.6K	﹤0.01%	1307

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

LSVM

Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return

KIA

Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

FineMark National Bank & Trust's ENZ Position: Q4 2015 in Review

FineMark National Bank & Trust sold out of Enzo Biochem, Inc. (ENZ) in Q4 2015, closing a stake of 527 shares — an estimated $2K sold.

FineMark National Bank & Trust first reported a position in ENZ in Q3 2015 and held it in 1 quarter. The position peaked at $2K in Q3 2015. 89 funds tracked by Wall St. Rank hold ENZ as of Q4 2015.

FineMark National Bank & Trust reported no remaining Enzo Biochem, Inc. position as of Q4 2015 after selling out during the quarter.
FineMark National Bank & Trust sold 527 Enzo Biochem, Inc. shares in Q4 2015, an estimated $2K.
FineMark National Bank & Trust first reported a position in Enzo Biochem, Inc. in Q3 2015 and held it in 1 quarter.
FineMark National Bank & Trust's Enzo Biochem, Inc. position peaked at $2K in Q3 2015.
89 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2015.

Based on FineMark National Bank & Trust's 13F filing for Q4 2015, filed 9 Feb 2016.